Alliance Pharma PLC has announced that its Chief Executive Officer, Peter Butterfield, and Chief Financial Officer, Andrew Franklin, have exercised share options under the company's Long Term Incentive Plan. Butterfield exercised options over 98,342 ordinary shares, while Franklin exercised options over 55,592 ordinary shares. Following the exercise, both executives sold a portion of their shares. Butterfield sold 74,343 shares, while Franklin sold 42,053 shares. The shares were sold at a price of £0.39016 per share. Both executives still hold a significant number of shares and vested but unexercised share options.